Search

Author/Creator Sierra, J.

1. 90 INTENSIVE CHEMOTHERAPY VERSUS NO INTENSIVE TREATMENT IN HIGH RISK MYELODYSPLASTYC SYNDROME (MDS) NO-HSCT CANDIDATES. (April 2015)

Authors:
Bargay, J.; Xicoy, B.; Brunet, S.; Tormo, M.; Pedro, C.; Coll, R.; Talarn, C.; Marti, J.M.; Nomdedeu, M.; Font, X.; Sampol, A.; Borrás, J.; Valcárcel, D.; Ribera, J.M.; Sierra, J.
Journal:
Leukemia research
Issue:
Volume 39(2015:Apr.) Supplement 1
Page Start:
S46
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Assessment of Confirmed Clinical Hypersensitivity to Rituximab in Patients Affected with B-Cell Neoplasia. (11th June 2020)

Authors:
Novelli, S.; Soto, L.; Caballero, A.; Moreno, M. E.; Lara, M. J.; Bayo, D.; Quintas, A.; Jimeno, P.; Zamora, M. I.; Bigorra, T.; Sierra, J.; Briones, J.
Other Names:
Lwaleed Bashir A. Academic Editor.
Journal:
Advances in hematology
Issue:
Volume 2020(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗